Trials / Completed
CompletedNCT02062060
Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
A Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 325 (actual)
- Sponsor
- Dr. Reddy's Laboratories Limited · Industry
- Sex
- All
- Age
- 6 Months
- Healthy volunteers
- Not accepted
Summary
Purpose of this study is to evaluate the efficacy of at-home administration of a single application of abametapir lotion 0.74% w/w for the treatment of head lice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Abametapir Lotion 0.74% w/w | |
| DRUG | Vehicle Lotion |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2014-07-01
- Completion
- 2014-08-01
- First posted
- 2014-02-13
- Last updated
- 2020-05-12
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02062060. Inclusion in this directory is not an endorsement.